Anúncio
Anúncio

CLNN

CLNN logo

Clene Inc. Common Stock

6.23
USD
Patrocinado
+0.47
+8.23%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

6.13

-0.11
-1.75%

Relatórios de Lucros CLNN

Rácio de surpresa positiva

CLNN separação 11 de 20 últimas estimativas.

55%

Próximo Relatório

Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$49.98K
/
-$0.56
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+233.20%
/
-34.12%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-45.08%
/
-69.89%

Clene Inc. Common Stock earnings per share and revenue

On 13 de nov. de 2025, CLNN reported earnings of -0.85 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -43.68% surprise. Revenue reached 15.00 mil, compared to an expected 56.24 mil, with a -73.33% difference. The market reacted with a -22.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.56 USD, with revenue projected to reach 49.98 mil USD, implying an diminuir of -34.12% EPS, and aumentar of 233.20% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, Clene Inc. Common Stock reported EPS of -$0.85, missing estimates by -43.68%, and revenue of $15.00K, -73.33% below expectations.
The stock price moved down -22.42%, changed from $9.41 before the earnings release to $7.30 the day after.
The next earning report is scheduled for 23 de mar. de 2026.
Based on 9 analistas, Clene Inc. Common Stock is expected to report EPS of -$0.56 and revenue of $49.98K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio